Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,570,938
+$141,694 QoQ
Shares Held
10,123
+1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#2,135
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Marshall Financial Group, LLC holds $15,627,500 across 8 Drug Manufacturers - General names. JNJ ranks #3 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
35,820 | $4,602,870 | |
| 2 | NVS |
Novartis AG
|
17,632 | $2,763,287 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
10,123 | $2,570,938 | |
| 4 | AMGN |
Amgen Inc
|
6,736 | $2,439,240 | |
| 5 | LLY |
ELI LILLY & Co
|
1,613 | $1,934,680 | |
| 6 | AZN |
Astrazeneca PLC
|
4,153 | $787,491 | |
| 7 | NVO |
Novo Nordisk A S
|
5,607 | $268,799 | |
| 8 | ABBV |
AbbVie Inc.
|
1,034 | $260,195 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,570,938 | 10,123 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,429,244 | 9,938 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2,206,707 | 10,663 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $2,257,117 | 12,173 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $1,856,370 | 12,153 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $2,036,681 | 12,281 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $1,653,729 | 11,435 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $878,689 | 5,422 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $762,224 | 5,215 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $907,061 | 5,734 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $904,546 | 5,771 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $2,351,980 | 15,101 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $2,712,210 | 16,386 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $2,547,890 | 16,438 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $2,861,200 | 16,197 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $2,031,054 | 12,433 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $2,220,295 | 12,508 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $2,444,533 | 13,793 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,393,953 | 13,994 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $1,415,547 | 8,765 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,607,038 | 9,755 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $2,513,075 | 15,291 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $2,217,641 | 14,091 | Shares | Sole | 2021-01-29 | |
| No filing history on record for this holder in this stock. | ||||||